Eisai will request reconsideration of initial decision for lecanemab in Australia
Go back to Eisai will request reconsideration of initial decision for lecanemab in Australia| BARNES GROUP, Inc. (NYSE: B) | Delayed: 36.73 -0.97 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.70 | 52 Week High | $44.27 | |||
| Open | $37.09 | 52 Week Low | $30.07 | |||
| Day High | $37.26 | P/E | 28.04 | |||
| Day Low | $36.19 | EPS | $1.31 | |||
| Volume | 6,264,664 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 9.04 -15.81 (63.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.85 | 52 Week High | $8.73 | |||
| Open | $8.77 | 52 Week Low | $2.86 | |||
| Day High | $10.81 | P/E | N/A | |||
| Day Low | $8.65 | EPS | $-3.82 | |||
| Volume | 9,975,224 | |||||
